|
JAMA |
How to Use and Interpret the Results of a Platform Trial - Users' Guide to the Medical Literature |
1 |
Yes |
1/4/2025 |
|
JAMA |
Humanism Before Heroism in Medicine |
1 |
Yes |
6/21/2024 |
|
JAMA |
Hypernatremia |
1 |
Yes |
2/22/2025 |
|
JAMA |
Hyperthyroidism - A Review |
1 |
Yes |
10/17/2024 |
|
JAMA |
Identifying Children Likely to Benefit From Antibiotics for Acute Sinusitis - A Randomized Clinical Trial |
1 |
Yes |
7/25/2026 |
|
JAMA |
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women |
1 |
Yes |
5/14/2024 |
|
JAMA |
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals |
1 |
Yes |
12/21/2024 |
|
JAMA |
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines |
1 |
Yes |
10/26/2025 |
|
JAMA |
Incorporation of Social Risk in US Preventive Services Task Force Recommendations and Identification of Key Challenges for Primary Care |
1 |
Yes |
10/12/2024 |
|
JAMA |
Inflammatory Myositis in a Patient With Melanoma |
1 |
Yes |
8/9/2024 |
|
JAMA |
Instrumental Variables and Heterogeneous Treatment Effects |
1 |
Yes |
3/22/2025 |
|
JAMA |
Intermittent Chest Pain in a 46-Year-Old Patient |
1 |
Yes |
10/31/2025 |
|
JAMA |
Interpreting SARS-CoV-2 Test Results |
1 |
Yes |
9/17/2024 |
|
JAMA |
Intravenous Vitamin C for Patients Hospitalized With COVID-19 - Two Harmonized Randomized Clinical Trials |
1 |
Yes |
10/25/2026 |
|
JAMA |
Joint Pain in a Woman Wearing a Face Mask |
1 |
Yes |
3/17/2025 |
|
JAMA |
Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents |
1 |
Yes |
8/4/2024 |
|
JAMA |
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry |
1 |
Yes |
8/1/2026 |
|
JAMA |
Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates |
1 |
Yes |
8/4/2024 |
|
JAMA |
Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia |
1 |
Yes |
6/1/2024 |
|
JAMA |
Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia - Review |
1 |
Yes |
6/1/2024 |
